{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:02:30Z","timestamp":1785769350718,"version":"3.56.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jogc.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jogc.2024.102663","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T20:41:26Z","timestamp":1726778486000},"page":"102663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["First- and Second-Trimester Aneuploidy Screening Biomarkers and Risk Assessment of Placenta Previa and Accreta: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"46","author":[{"given":"Anastasia","family":"Mortaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Douligeris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michail","family":"Panagiotopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Anastasia","family":"Daskalaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilios","family":"Pergialiotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Antsaklis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Daskalakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Theodora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2024.102663_bib1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejogrb.2013.08.030","article-title":"Real increasing incidence of hysterectomy for placenta accreta following previous caesarean section","volume":"171","author":"Higgins","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jogc.2024.102663_bib2","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.ajog.2005.06.037","article-title":"Placenta previa-accreta: risk factors and complications","volume":"193","author":"Usta","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102663_bib3","doi-asserted-by":"crossref","first-page":"219.e1","DOI":"10.1016\/j.ajog.2012.12.037","article-title":"Placenta accreta: risk factors, perinatal outcomes, and consequences for subsequent births","volume":"208","author":"Eshkoli","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102663_bib4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1515\/jpm-2012-0219","article-title":"Placenta accreta and the risk of adverse maternal and neonatal outcomes","volume":"41","author":"Balayla","year":"2013","journal-title":"J\u00a0Perinat Med"},{"key":"10.1016\/j.jogc.2024.102663_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/1507674","article-title":"Placenta accreta spectrum: a review of pathology, molecular biology, and biomarkers","volume":"2018","author":"Bartels","year":"2018","journal-title":"Dis Markers"},{"key":"10.1016\/j.jogc.2024.102663_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jogc.2024.102663_bib7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jogc.2024.102663_bib8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cct.2006.04.004","article-title":"Random-effects model for meta-analysis of clinical trials: an update","volume":"28","author":"DerSimonian","year":"2007","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.jogc.2024.102663_bib9","first-page":"35","article-title":"Association between maternal serum alpha-fetoprotein and adverse outcomes in pregnancies with placenta previa","volume":"97","author":"Butler","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102663_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/pd.4277","article-title":"Elevated first trimester PAPP-A is associated with increased risk of placenta accreta","volume":"34","author":"Desai","year":"2014","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2024.102663_bib11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/(SICI)1097-0223(200002)20:2<100::AID-PD767>3.0.CO;2-5","article-title":"Maternal serum second trimester AFP and hCG in pregnancies with placenta previa","volume":"20","author":"Heikkil\u00e4","year":"2000","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2024.102663_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/14767050410001728935","article-title":"Association of maternal serum alpha-fetoprotein with persistent placenta previa","volume":"16","author":"Koster","year":"2004","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jogc.2024.102663_bib13","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/jp.2015.40","article-title":"Maternal serum markers, characteristics and morbidly adherent placenta in women with previa","volume":"35","author":"Lyell","year":"2015","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.jogc.2024.102663_bib14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4274\/tjod.00922","article-title":"The role of unexplained high serum alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in the second trimester to determine poor obstetric outcomes","volume":"11","author":"\u00d6zt\u00fcrk","year":"2014","journal-title":"Turk J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102663_bib15","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/1471-0528.13298","article-title":"First trimester maternal serum biochemical markers of aneuploidy in pregnancies with abnormally invasive placentation","volume":"122","author":"Thompson","year":"2015","journal-title":"BJOG"},{"key":"10.1016\/j.jogc.2024.102663_bib16","first-page":"545","article-title":"Risk factors for placenta accreta","volume":"93","author":"Hung","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102663_bib17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000492829","article-title":"Second trimester biochemical markers as possible predictors of pathological placentation: a retrospective case-control study","volume":"46","author":"Berezowsky","year":"2019","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.jogc.2024.102663_bib18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/14767058.2016.1275546","article-title":"Relationship between first trimester aneuploidy screening test serum analytes and placenta accreta","volume":"31","author":"B\u00fcke","year":"2018","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jogc.2024.102663_bib19","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/pd.3932","article-title":"Second-trimester maternal serum markers and placenta accreta","volume":"32","author":"Dreux","year":"2012","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2024.102663_bib20","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.kjms.2016.08.011","article-title":"Analysis of first and second trimester maternal serum analytes for the prediction of morbidly adherent placenta requiring hysterectomy","volume":"32","author":"Oztas","year":"2016","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.jogc.2024.102663_bib21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ijgo.12352","article-title":"Second-trimester levels of fetoplacental hormones among women with placenta accreta spectrum disorders","volume":"140","author":"Pekar-Zlotin","year":"2018","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.jogc.2024.102663_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1515\/jpm-2019-0261","article-title":"Significance of the routine first-trimester antenatal screening program for aneuploidy in the assessment of the risk of placenta accreta spectrum disorders","volume":"48","author":"Penzhoyan","year":"2019","journal-title":"J\u00a0Perinat Med"},{"key":"10.1016\/j.jogc.2024.102663_bib23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.5152\/jtgga.2014.14045","article-title":"Changes in first trimester screening test parameters in pregnancies complicated by placenta previa and association with hyperemesis gravidarum","volume":"15","author":"T\u00fclek","year":"2014","journal-title":"J\u00a0Turkish German Gynecol Assoc"},{"key":"10.1016\/j.jogc.2024.102663_bib24","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00404-020-05960-1","article-title":"First trimester serum PAPP-A is associated with placenta accreta: a retrospective study","volume":"303","author":"Wang","year":"2021","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jogc.2024.102663_bib25","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S1701-2163(16)32973-5","article-title":"RETIRED: obstetrical complications associated with abnormal maternal serum markers analytes","volume":"30","author":"Gagnon","year":"2008","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2024.102663_bib26","article-title":"Prediction of pregnancy complications with maternal biochemical markers used in Down syndrome screening","volume":"14","author":"Ozdemir","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.jogc.2024.102663_bib27","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/AOG.0b013e3181da93da","article-title":"First- and second-trimester maternal serum markers for aneuploidy and adverse obstetric outcomes","volume":"115","author":"Dugoff","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102663_bib28","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jogc.2018.12.004","article-title":"No. 383-screening, diagnosis, and management of placenta accreta spectrum disorders","volume":"41","author":"Hobson","year":"2019","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2024.102663_bib29","article-title":"Placenta accreta spectrum disorders: a national survey","volume":"45","author":"L\u00e9tourneau","year":"2023","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2024.102663_bib30","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMcp1709324","article-title":"Placenta accreta spectrum","volume":"378","author":"Silver","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jogc.2024.102663_bib31","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/jum.15530","article-title":"Predicting placenta accreta spectrum: validation of the placenta accreta index","volume":"40","author":"Happe","year":"2021","journal-title":"J\u00a0Ultrasound Med"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216324004869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216324004869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T14:17:04Z","timestamp":1733149024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216324004869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1701216324004869"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2024.102663","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First- and Second-Trimester Aneuploidy Screening Biomarkers and Risk Assessment of Placenta Previa and Accreta: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2024.102663","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102663"}}